Up to 1,500 investors in Keydata-style life settlement-backed products have been told they will receive a fraction of their expected return because the bonds failed to get regulatory approval.
UK investors in ARM Asset Backed Securities, a Luxembourg-based special purpose vehicle, have received letters stating regulatory approval for their investments has not been given, the Financial Times reports. They are being offered returns as low as 0.14% on their £36m investment pool on bonds which promised up to 9% per year. ARM has been trying to gain authorisation from the Luxembourg regulator (CSSF) since last July but continued to sell the products without approval. Investors‘ money has been held in holding accounts accruing interest of 0.14% until the bonds could be boug...
To continue reading this article...
Join Professional Adviser for free
- Unlimited access to real-time news, industry insights and market intelligence
- Stay ahead of the curve with spotlights on emerging trends and technologies
- Receive breaking news stories straight to your inbox in the daily newsletters
- Make smart business decisions with the latest developments in regulation, investing retirement and protection
- Members-only access to the editor’s weekly Friday commentary
- Be the first to hear about our events and awards programmes